The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

have demonstrated remarkable performance in tasks involving graph-structured data, but they also exhibit biases linked to node degrees. This paper explores a specific manifestation of such bias, ...